Tickerplace logo

Tickerplace

BioMarin Pharmaceutical Inc. logo

BMRNBioMarin Pharmaceutical Inc.

BMRN Stock Price, Valuation & Chart | BioMarin Pharmaceutical Inc.

Compare
$54.680-1.37 (-2.44%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

BMRN Historical price chart

BMRN Key Stats

Market Capitalization10.58B
PE Ratio26.29
EPS2.08
Trading Volume2.62M
Today's High/Low56.4/54.45
Dividend Yield0.00
52 Week High/Low70.98/49.26
Shares Outstanding193.57M
BMRN Financial Statement
BMRN Analyst ratings
BMRN Analysis & performance metrics

BMRN Company profile

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products…

BMRN Management team

Management
Ganesh Vedantham Ph.D.
Senior Vice President of Technical Development
George Eric Davis J.D.
Executive Vice President, Chief Legal Officer, General Counsel & Secretary
Gregory Friberg M.D.
Executive Vice President and Chief Research & Development Officer
Brian R. Mueller CPACFO
Executive Vice President of Finance & Chief Financial Officer
Cristin Hubbard
Executive Vice President & Chief Commercial Officer
Amy Wireman
Executive Vice President & Chief People Officer
Alexander HardyCEO
President, Chief Executive Officer & Director
Erin Burkhart
Group Vice President & Chief Accounting Officer
Total 8 executives

BMRN Frequently asked questions

What is BioMarin Pharmaceutical Inc. (BMRN) Stock Price?

Current stock price of BioMarin Pharmaceutical Inc. (BMRN) stock is $54.680. The stock price is -2.44% lower in the session. The intraday range can be seen from this page. Volume of BioMarin Pharmaceutical Inc. (BMRN) stock is 2.62M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the BioMarin Pharmaceutical Inc. (BMRN) stock price going up or down today?

The stock price of BioMarin Pharmaceutical Inc. (BMRN) can change with earnings, company news, and overall market sentiment. BioMarin Pharmaceutical Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the BioMarin Pharmaceutical Inc. stock expensive at its current price?

Whether BioMarin Pharmaceutical Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BMRN on this page is 26.29. EPS on this page is 2.08. Compare those figures with peers and growth expectations before deciding if the current BioMarin Pharmaceutical Inc. price is justified.

How has the stock price of BioMarin Pharmaceutical Inc. (BMRN) performed historically?

Historical performance for BioMarin Pharmaceutical Inc. (BMRN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BMRN reacted to past earnings and market events.

Should I buy BioMarin Pharmaceutical Inc. (BMRN) stock, at this price?

Buying BioMarin Pharmaceutical Inc. (BMRN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.